e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Clinical Trial presentation and discussion "Cysteinyl leukotrienes and paediatric asthma: a new horizon or a blind alley?"
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Genetics of LT production and activity in asthma
I. Sayers (Nottingham, United Kingdom)
Source:
International Congress 2014 – Clinical Trial presentation and discussion "Cysteinyl leukotrienes and paediatric asthma: a new horizon or a blind alley?"
Session:
Clinical Trial presentation and discussion "Cysteinyl leukotrienes and paediatric asthma: a new horizon or a blind alley?"
Session type:
Symposium
Number:
3214
Disease area:
Airway diseases, Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Sayers (Nottingham, United Kingdom). Genetics of LT production and activity in asthma. International Congress 2014 – Clinical Trial presentation and discussion "Cysteinyl leukotrienes and paediatric asthma: a new horizon or a blind alley?"
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Importance of levels production of Il-4 in the pathogenesis and formation of the phenotype of asthma
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Increased serum levels of soluble IL-18 receptor complex in allergic asthma
Source: Annual Congress 2013 –Asthma
Year: 2013
Levels of cytokines, sCD31 and expression of CD38 in patients with bronchial asthma of various severity out of a disease exacerbation
Source: International Congress 2014 – Biomarkers of asthma and clinical immunology
Year: 2014
Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
TLR-3 triggered exacerbation of experimental asthma depends on IL-17 producing NK cells
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Correlation between asthma control and serum levels of IL-33 in atopic asthma
Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology
Year: 2016
Over-expression of the LTC4 synthase gene in mice reproduces human aspirin-induced asthma (AIA)
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
The homologous IL-17 cytokines A and F differentially regulate allergic asthma in murine models
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
Activation of the β-catenin pathway by Wnt-1 treatment suppress inflammation in the mouse model of allergic airway disease
Source: International Congress 2015 – Advances in asthma and allergy in animal models
Year: 2015
GLCCI1
variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014
Implication of interleukin-10 in the development of COPD induced by cigarette smoke exposure in mice
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Free serum IL-18 levels and responsiveness to omalizumab in patients with severe asthma
Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding
Year: 2016
IL-13-induced cytokine release and hyperresponsiveness in precision cut lung slices of different species – Characterization of a model potentially suitable for translational research of asthma cellular events
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013
The role of IL-13, IL-4Rα cytokine gene variants in atopic and non-atopic asthma
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Expression of genes associated with neurogenic inflammation in pediatric asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013
Elevated IL-17A in very severe COPD is localized to mast cells and correlates with lung function decline
Source: International Congress 2014 – TH17 and other acute asthmatic responses
Year: 2014
Lung specific induction of Wnt-1 has a prophylactic and therapeutic effect on the development of an allergic airway disease
Source: Annual Congress 2013 –Murine models of lung immunology
Year: 2013
Concomitant use of fractional exhaled nitric oxide (FeNO) and asthma control test (ACT) as markers for predicting asthma exacerbation
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
IL-4 polymorphisms in intrinsic and extrinsic asthma in a Greek population
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
The immunomodulatory activity of protein S protects against allergic airway inflammation
Source: International Congress 2015 – Immune mechanisms in the human lung
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept